Americhem acquires Noble Biomaterials
Americhem, a global designer and manufacturer of custom polymer solutions, announced the acquisition of Noble Biomaterials, an advanced materials company that specializes in antimicrobial and conductivity solutions for soft surface applications.
“Americhem is the right partner for Noble Biomaterials’ next chapter, bringing complementary capabilities, global reach, scalable resources, and a customer-first culture that will drive lasting value,” said Joel Furey, Founder and Chief Commercial Officer of Noble Biomaterials.
The acquisition adds Noble Biomaterials’ differentiated technologies and deep specialization to Americhem’s broader global platform, strengthening Americhem’s ability to support customers from concept through scalable commercial production.
Noble Biomaterials provides proprietary materials technology for mission-critical applications across high-growth markets including apparel & textiles, healthcare, and aerospace & defense.
Its flagship platforms, IONIC+, X-STATIC, and CIRCUITEX, deliver advanced functional capabilities backed by U.S. manufacturing and a robust IP portfolio built over two decades.
Noble Biomaterials’ antimicrobial, odor control, and conductive technologies strengthen Americhem’s position in fiber and polymer solutions to capture significant growth across healthcare and other high-demand markets.
“Noble Biomaterials brings exceptional capabilities in antimicrobial solutions, strong commercial relationships and a reputation for quality that aligns with our values. We will be better positioned to deliver specialized solutions at a global scale as we make strategic investments to grow in healthcare and aerospace and defense,” said John Richard, Chief Executive Officer of Americhem.
